secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K/A
Filed at:   2026-08-07T21:00:14+00:00
Accession:  0001193125-26-340449
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics adds Mark Pavao to Audit Committee
----------------------------------------------------

- Mark H. Pavao appointed to Audit Committee effective Aug 6, 2026, on Board recommendation.
- Audit Committee now comprises Dov Goldstein (Chair), Ann Lee, Dieter Weinand, and Mark Pavao.
- Appointment follows Pavao's earlier board appointment effective April 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526340449/0001193125-26-340449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312526340449/d177510d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-340449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer